Histological Transformation to Large Cell Neuroendocrine Carcinoma from Lung Adenocarcinoma Harboring an <i>EGFR</i> Mutation: An Autopsy Case Report-Reference-Cited by-同舟云学术

Histological Transformation to Large Cell Neuroendocrine Carcinoma from Lung Adenocarcinoma Harboring an EGFR Mutation: An Autopsy Case Report

Published:2017 Issue:15 Volume:56 Page:2013-2017
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Moriya Rika¹,Hokari Satoshi¹,Shibata Satoshi¹,Koizumi Takeshi¹,Tetsuka Takafumi²,Ito Kazuhiko²,Hashidate Hideki³,Tsukada Hiroki²

Affiliation:

1. Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Japan

2. Department of Respiratory Medicine, Niigata City General Hospital, Japan

3. Department of Pathology, Niigata City General Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/56/15/56_56.7452/_pdf

Reference17 articles.

1. 1. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small cell lung cancer to gefitinib. N Engl J Med 350: 2129-2139, 2004.

2. 2. Jackman D, Pao W, Riely GJ, et al. Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer. J Clin Oncol 28: 357-360, 2010.

3. 3. Sequist LV, Waltman BA, Dias-Santagata D, et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med 3: 75ra26, 2011.

4. 4. Yatabe Y, Hida T, Horio Y, Kosaka T, Takahashi T, Mitsudomi T. A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer. J Mol Diagn 8: 335-341, 2006.

5. 5. Fasano M, Della Corte CM, Papaccio F, Ciardiello F, Morgillo F. Pulmonary large-cell neuroendocrine carcinoma: form epidemiology to therapy. J Thorac Oncol 10: 1133-1141, 2015.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategies;Critical Reviews in Oncology/Hematology;2024-04

2. Role of CDK4/6 inhibitors in targeting Rb proficient small cell lung cancer;Translational Lung Cancer Research;2024-01

3. Spontaneous histological transformation of lung squamous-cell carcinoma to large cell neuroendocrine carcinoma and small cell lung cancer;Journal of Cancer Research and Clinical Oncology;2023-06-28

4. Neuronal survival factor VGF promotes chemoresistance and predicts poor prognosis in lung cancers with neuroendocrine feature;International Journal of Cancer;2022-07-13

5. Targeting ALK in Neuroendocrine Tumors of the Lung;Frontiers in Oncology;2022-06-07